Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL)
Also known as: Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) / Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) / Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma / Lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) / CLL or SLL / CLL/SLL / CLL / SLL / Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma / Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09053 | Ibrutinib | An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09053 | Ibrutinib | Tyrosine-protein kinase BTK | target |
| DB09053 | Ibrutinib | Cytochrome P450 3A4 | enzyme |
| DB09053 | Ibrutinib | Cytochrome P450 3A5 | enzyme |
| DB09053 | Ibrutinib | Serum albumin | carrier |
| DB09053 | Ibrutinib | alpha1-acid glycoprotein | carrier |
| DB09053 | Ibrutinib | Cytochrome P450 2D6 | enzyme |